Page 8 - Peter Pickkers News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Proenkephalin (penKid®) included in the ADQI consensus statements publication as functional kidney biomarker for the management of AKI patients
The latest consensus meeting of international experts in critical care and nephrology supports the use of novel biomarkers in the prevention and management of Acute Kidney Injury (AKI)
The consensus recommends using a combination of damage and functional biomarkers together with clinical information for routine practice
Proenkephalin (penKid®), the kidney function biomarker, proposed as a marker for the assessment of AKI progression and kidney recovery
The CE-IVD marked assay for penKid® is available for point of care usage on the fully automated Nexus IB10 platform ....

San Diego , United States , Andreas Bergmann , Sphingotec Gmbh , J Nephrol Renovasc , Peter Pickkers Radboud University , Disease Quality Initiative , Clin Chem Lab , Nexus Dx Inc , Acute Kidney Injury , Acute Disease Quality Initiative , Care Unit , Peter Pickkers , Radboud University , Intj Nephrol Renovasc Dis , Acute Kidney Injury Biomarkers From , Consensus Statement , Critical Care Medicine , Early Biomarker , Septic Acute Kidney Injury , Septic Shock , Kidney Int Rep , New Biomarker , Pediatric Acute Kidney Injury , Children Under One Year , Clin Chem Lab Med ,